BLIS Technologies (NZSE:BLT) Cash Ratio : 6.97 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. BLIS Technologies's Cash Ratio for the quarter that ended in Mar. 2024 was 6.97.

BLIS Technologies has a Cash Ratio of 6.97. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for BLIS Technologies's Cash Ratio or its related term are showing as below:

NZSE:BLT' s Cash Ratio Range Over the Past 10 Years
Min: 0.61 Med: 2.18 Max: 6.97
Current: 6.97

During the past 13 years, BLIS Technologies's highest Cash Ratio was 6.97. The lowest was 0.61. And the median was 2.18.

NZSE:BLT's Cash Ratio is ranked better than
73.67% of 1504 companies
in the Biotechnology industry
Industry Median: 2.94 vs NZSE:BLT: 6.97

BLIS Technologies Cash Ratio Historical Data

The historical data trend for BLIS Technologies's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Cash Ratio Chart

BLIS Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash Ratio

Get a 7-Day Free Trial

2.00

1.25

5.81

5.27

6.97

BLIS Technologies Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Cash Ratio	Get a 7-Day Free Trial															5.81	5.71	5.27	5.25	6.97

Competitive Comparison of BLIS Technologies's Cash Ratio

For the Biotechnology subindustry, BLIS Technologies's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BLIS Technologies's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's Cash Ratio distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's Cash Ratio falls into.

BLIS Technologies Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

BLIS Technologies's Cash Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash Ratio (A: Mar. 2024 )	=	Cash, Cash Equivalents, Marketable Securities	/	Total Current Liabilities
	=	8.597	/	1.233
	=	6.97

BLIS Technologies's Cash Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash Ratio (Q: Mar. 2024 )	=	Cash, Cash Equivalents, Marketable Securities	/	Total Current Liabilities
	=	8.597	/	1.233
	=	6.97

BLIS Technologies (NZSE:BLT) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.

BLIS Technologies Cash Ratio Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies (NZSE:BLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Cash Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).